BMS-986165
BMS-986165 is a novel oral selective TYK2 inhibitor with a unique mechanism of action that is expected to provide a promising oral option to help patients effectively manage their psoriasis.
| Catalog Number | API1609392279 |
| Alternative Name(s) | Tyk2-IN-4;TYK2-IN-4;6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl) phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide;Deucravacitinib;Deucravacitinib(BMS986165) |
| Research Area | Hormone and Endocrine Regulation APIs |
| Molecular Formula | C20H22N8O3 |
| CAS# | 1609392-27-9 |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/bms-986165-item-10013.html |